Increased vasoconstriction to noradrenaline by 1400W, inhibitor of iNOS, in rats with streptozotocin-induced diabetes

European Journal of Pharmacology

Volumn 484, Issue 2-3, 2004, Pages 263-268

  Cheng, Xing ^a   Pang, Catherine C Y ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Capacitance; Mean circulatory filling pressure; Noradrenaline; Vasoconstriction

Indexed keywords

N 3 AMINOMETHYLBENZYL ACETAMIDINE; N [3 (AMINOMETHYL)BENZYL]ACETAMIDINE; NITRIC OXIDE SYNTHASE INHIBITOR; NORADRENALIN; PROPRANOLOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; DRUG MECHANISM; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE FILLING; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; VASOCONSTRICTION;

EID: 1642464841     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2003.11.002     Document Type: Article

References (29)

1. Alderton W.K., Cooper C.E., Knowles R.G. Nitric oxide synthases: structure, function and inhibition. Biochem. J. 357(Pt. 3):2001;593-615. (Review).
2. Bardell A.L., MacLeod K.M. Evidence for inducible nitric-oxide synthase expression and activity in vascular smooth muscle of streptozotocin-diabetic rats. J. Pharmacol. Exp. Ther. 296:2001;252-259.
3. Ceriello A., Quagliaro L., D'Amico M., Di Filippo C., Marfella R., Nappo F., Berrino L., Rossi F., Giugliano D. Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat. Diabetes. 51:2002;1076-1082.
4. Chakravarthy U., Hayes R.G., Stitt A.W., McAuley E., Archer D.B. Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end products. Diabetes. 47:1998;945-952.
5. Cheng X., Leung S.W., Lim S.L., Pang C.C.Y. Attenuated arterial and venous constriction in conscious rats with streptozotocin-induced diabetes. Eur. J. Pharmacol. 58:2003;299-304.
6. Cheng X., Leung S.W., Lo L., Pang C.C.Y. Selective versus non-selective suppression of nitric oxide synthase on regional haemodynamics in rats with or without LPS-induced endotoxaemia. Naunyn-Schmiedebergs Arch. Pharmakol. 367:2003;372-379.
7. Foy J.M., Lucas P.D. Effect of experimental diabetes, food deprivation and genetic obesity on the sensitivity of pithed rats to autonomic agents. Br. J. Pharmacol. 57:1976;229-234.
8. Guyton A.C. Venous return. Hamilton W.F., Dow P. Handbook of Physiology. vol. II:1963;1099-1133 American Physiological Society, Washington, DC.
9. Guyton A.C., Polizo D., Armstrong G.G. Mean circulation filling pressure measured immediately after cessation of heart pumping. Am. J. Physiol. 179:1954;261-267.
10. Garvey E.P., Oplinger J.A., Tanoury G.J., Sherman P.A., Fowler M., Marshall S., Harmon M.F., Paith J.E., Furfine E.S. Potent and selective inhibition of human nitric oxide synthases. Inhibition by non-amino acid isothioureas. J. Biol. Chem. 269:1994;26669-26676.
11. Garvey E.P., Oplinger J.A., Furfine E.S., Kiff R.J., Laszio F., Whittle B.J.R., Knowles R.G. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J. Biol. Chem. 272:1997;4959-4963.
12. Hebden R.A., Bennett T., Gardiner S.M. Pressor sensitivities to vasopressin, angiotensin II, or methoxamine in diabetic rats. Am. J. Physiol. 253:1987;R726-R734.
13. Jackson C.V., Carrier G.O. Influence of short-term experimental diabetes on blood pressure and heart rate in response to norepinephrine and angiotensin II in the conscious rat. J. Cardiovasc. Pharmacol. 5:1983;260-265.
14. Lucas P.D. Effects of streptozotocin-induced diabetes and noradrenaline infusion on cardiac output and its regional distribution in pithed rats. Diabetologia. 28:1985;108-112.
15. Makino A., Kamata K. Elevated plasma endothelin-1 level in streptozotocin-induced diabetic rats and responsiveness of the mesenteric arterial bed to endothelin-1. Br. J. Pharmacol. 123(6):1998;1065-1072.
16. McNeill J.H. Experimental Models of Diabetes. 1999;C.R.C. Press, Boca Raton, FL.
17. Misurski D.A., Hopfner R.L., Gopalakrishnan V. Attenuated agonist evoked vasoconstrictor responses in the perfused mesenteric vascular bed of streptozotocin diabetic rats. Exp. Biol. Med. 226(10):2001;940-946.
18. Ng S.S.W., Pang C.C.Y. Venous versus arterial actions of diethylamine/nitric oxide (DEA/NO) complex and S-nitroso-N-acetylpenicillamine (SNAP) in vivo. Br. J. Pharmacol. 125:1998;1247-1251.
19. Pang C.C.Y. Measurement of body venous tone. J. Pharmacol. Methods. 44:2000;341-361.
20. Rothe C.F. Mean circulatory filling pressure: its meaning and measurement. J. Appl. Physiol. 74:1993;499-509.
21. Sambandam N., Abrahani M.A., Craig S., Al-Atar O., Jeon E., Rodrigues B. Metabolism of VLDL is increased in streptozotocin-induced diabetic rat hearts. Am. J. Physiol. 278:2000;H1874-H1882.
22. Smith J.M., Paulson D.J., Romano F.D. Inhibition of nitric oxide synthase by L-NAME improves ventricular performance in streptozotocin-diabetic rats. J. Mol. Cell. Cardiol. 29:1997;2393-2402.
23. Stockklauser-Färber K., Ballhausen T.H., Laufer A., Rösen P. Influence of diabetes on cardiac nitric oxide synthase expression and activity. Biochim. Biophys. Acta. 1535:2000;10-20.
24. Tannous M., Rabini R.A., Vignini A., Moretti N., Fumelli P., Zielinski B., Mazzanti L., Mutus B. Evidence for iNOS-dependent peroxynitrite production in diabetic platelets. Diabetologia. 42:1999;539-544.
25. Wray G.M., Millar C.G., Hinds C.J., Thiemermann C. Selective inhibition of the activity of inducible nitric oxide synthase prevents the circulatory failure, but not the organ injury/dysfunction, caused by endotoxin. Shock. 9:1998;329-335.
26. Yamamoto J., Trippodo N.C., Ishise S., Frohlich E.D. Total vascular pressure-volume relationship in the conscious rat. Am. J. Physiol. 238:1980;H823-H828.
27. Yu Z., McNeill J.H. Blood pressure and heart rate response to vasoactive agents in conscious diabetic rats. Can. J. Physiol. Pharm. 70:1992;1542-1548.
28. Zanzinger J., Czachurski J., Seller H. Inhibition of sympathetic vasoconstriction is a major principle of vasodilation by nitric oxide in vivo. Circ. Res. 75(6):1994;1073-1077.
29. Zou M.H., Shi C., Cohen R.A. High glucose via peroxynitrite causes tyrosine nitration and inactivation of prostacyclin synthase that is associated with thromboxane/prostaglandin H(2) receptor-mediated apoptosis and adhesion molecule expression in cultured human aortic endothelial cells. Diabetes. 51(1):2002;198-203.